MD Pharma

Name

MD Pharma

Legal name

MD Pharma

Website

https://mdpharma.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Commercialization Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK), Specialty Care Pharmaceuticals (HLAIAAAB), Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Pharmaceutical commercialization
• Pharmaceutical distribution services
• Regulatory affairs services
• Pharmacovigilance services
• Pharmaceutical sales representation

Headquarters

HQ city

Heredia

HQ country

Costa Rica

HQ region

Latin America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Commercialization: MD Pharma generates revenue by commercializing and promoting pharmaceutical products on behalf of laboratories in Central America and the Caribbean. As a strategic commercial partner, it handles sales, marketing, distribution, pharmacovigilance, and regulatory affairs for pharmaceutical brands. Revenue is earned through commercial representation agreements, outsourcing fees, licensing arrangements, and custom business models with laboratory partners.

Go-to-market motion2 records

Core offering

MD Pharma is a pharmaceutical commercialization partner that sells, markets, distributes, and provides regulatory and pharmacovigilance support for pharmaceutical and dermo-cosmetic products on behalf of international laboratories across Central America and the Caribbean. The company operates four flexible business models (Regional Laboratory Representation, Outsourcing, Licenses, and Ad HOC) to commercialize 160+ brands from 14 laboratories spanning ophthalmology, aesthetics, cardiology, dermatology, neurology, gastroenterology, and respiratory therapeutic areas. It manages the full commercial lifecycle under international ethical and compliance standards.

Product overview

MD Pharma is not a software product company but a pharmaceutical commercialization and marketing company operating across Central America and the Caribbean. The company's offering consists of a diversified portfolio of over 160 pharmaceutical and dermo-cosmetics brands commercialized under four distinct business models: Regional Laboratory Representation, Outsourcing, Licenses, and Ad Hoc models. The portfolio spans multiple therapeutic areas and product categories organized by partner laboratories, including: Ab-Biotics (probiotics — AB-Digest, AB-Immuno, AB-Colic, AB-Life, AB Sakei, AB Mind, PROBIO I3.1); AbbVie Eye Care (ophthalmics — Refresh, Optive, Lumigan, Combigan, Alphagan P, Acular LS, Zymaxid, Zypred); Allergan Aesthetics (hyaluronic acid dermal fillers — Juvederm Voluma, Volux, Volbella, Volift, Volite); AstraZeneca (respiratory — SYMBICORT, PULMICORT; cardiovascular — CRESTOR, BRILINTA, ATACAND, BETALOC ZOK; diabetes — XIGDUO XR, KOMBIGLYZE XR, FORXIGA; gastroenterology — NEXIUM; nephrology — Edistride); Atnahs (bone health — Bonviva, Bondronat; antiemetic — Kytril); Carnot (cardiovascular); Ferrer (CNS — SOMAZINA, SINCRONIUM, PSICO-SOMA; gastroenterology — HIDRASEC; cardiology — OMACOR, NUCLEO CMP FORTE; dermatology — GAMALATE; Dislep; ANGI NOVAG); Fertypharm (fertility — Fertybiotic); Isdin (dermo-cosmetics — ISDINCEUTICS anti-aging serums and creams, FOTOP and FOTOULTRA sunscreen lines, LAMBDAPIL hair care, ISDIN Si Nails, Micellar Solution); Medinfar (ALOPEXYL hair growth); Salvat (dermatology, gastroenterology, otology); Unión Química (women's health — Microgynon, Triquilar, Climene, Femiane); and Viatris (rheumatology — SUPLASYN, GO-ON). The company markets these products through a direct sales force and medical representative network across Costa Rica, Honduras, Panama, Guatemala, Dominican Republic, Nicaragua, El Salvador, and additional Caribbean markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Regional Laboratory Representation A commercial representation service where MD Pharma acts as the regional partner for a pharmaceutical laboratory, handling the full commercial lifecycle including sales, marketing, distribution, regulatory affairs, and pharmacovigilance for the partner's products across Central America and the Caribbean. Targeted at pharmaceutical laboratories seeking market entry or expansion in the region.
• Outsourcing An outsourcing service where pharmaceutical laboratories delegate specific commercial or operational functions (such as sales force deployment, marketing, distribution, or regulatory affairs) to MD Pharma across the Central American and Caribbean region under international ethical and compliance standards.
• Licensing (Licencias) A licensing service through which MD Pharma manages licensed pharmaceutical products on behalf of laboratory partners in the Central American and Caribbean region, handling commercialization, marketing, distribution, and regulatory compliance.
• AD HOC Custom Business Models Custom-tailored commercial engagement models designed by MD Pharma to address the specific needs of pharmaceutical laboratory partners that do not fit standard representation, outsourcing, or licensing structures, while maintaining international ethical and best-practice standards.
• Regulatory Affairs Services Regulatory affairs support covering marketing authorizations, post-registration changes, and compliance with health authorities across multiple Central American and Caribbean countries. Provided to pharmaceutical laboratory partners to ensure product compliance in each jurisdiction of operation.
• Pharmacovigilance Services Pharmacovigilance services including adverse event monitoring, reporting, and post-marketing safety surveillance for pharmaceutical products commercialized on behalf of partner laboratories across the Central American and Caribbean region.
• Pharmaceutical and OTC Logistics Services Regional logistics services for pharmaceutical and OTC products covering import, export, storage, distribution, and quality assurance across Central America and the Caribbean. Provided to laboratory partners to enable last-mile distribution of their products in the region.
• Medical Representative Sales Force Services Deployment of a direct field sales force of medical representatives who schedule appointments and conduct promotional visits with healthcare professionals (doctors and specialists) to present and promote pharmaceutical products on behalf of laboratory partners across Central America and the Caribbean.
• Juvederm (Allergan Aesthetics) — Nicaragua Launch Market launch of the Juvéderm line of hyaluronic acid dermal fillers (Voluma, Volux, Volbella, Volift, Volite) from Allergan Aesthetics in Nicaragua in September 2024 for facial volumization, contouring, lip enhancement, and skin quality improvement.
• Suplasyn 1-SHOT — Guatemala and Honduras Launch Launch of Suplasyn 1-SHOT (single-injection hyaluronic acid viscosupplementation) from Viatris in Guatemala and Honduras during the second semester of 2024 for the symptomatic treatment of osteoarthritis and improvement of joint function.
• Suplasyn 1-SHOT — El Salvador Launch Launch of Suplasyn 1-SHOT (single-injection hyaluronic acid viscosupplementation) from Viatris in El Salvador during the second half of 2024 for the symptomatic treatment of osteoarthritis and joint function improvement.

Quantifiable outcome

• More than 160 brands commercialized across 14 countries/territories
• +2 more outcomes

Named customers14 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

15 partnerships are on record, tiered core.

• AbbVie Eye CarecoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes ophthalmology products from AbbVie Eye Care (including brands such as Lumigan, Alphagan P, Combigan, Refresh Tears, Optive, Zymaxid, Zypred, Acular LS) in the Central American and Caribbean region. MD Pharma handles the full commercial lifecycle including sales, marketing, and distribution.
• AbbVie SpecialtycoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes specialty pharmaceutical products from AbbVie Specialty (including Botox) in the Central American and Caribbean region. MD Pharma manages the regional commercialization and promotion of these specialty brands.
• Allergan AestheticscoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes aesthetic medicine products from Allergan Aesthetics, including the Juvéderm line of hyaluronic acid dermal fillers (Voluma, Volux, Volbella, Volift, Volite) in Central America. The partnership has included product launches in new markets such as Nicaragua.
• AstraZenecacoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes a broad portfolio of products from AstraZeneca including cardiovascular (Atacand, Atacand Plus, Betaloc Zok, Brilinta, CrestOR), respiratory (Symbicort, Pulmicort), and metabolic products (Xigduo XR, Forxiga, Kombiglyze XR, Edistride, Nexium) across the Central American and Caribbean region.
• FerrercoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes neurological and specialty products from Ferrer (including Somazina, Sincronium, Psico-Soma, Gamalate, Nucleo CMP Forte, Omacor, Hidrasec, Dislep, Anginovag) in the Central American and Caribbean region.
• IsdincoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes dermatology and fotoprotection products from ISDIN, including the ISDINCEUTICS skincare line (Glicoisdin, Melaclear, K-Ox Eyes, A.G.E Reverse, Flavo-C, Night Peel, Pigment Expert), FOTOP and FOTOULTRA sunscreen lines, LAMBDAPIL hair loss line, ISDIN Micellar Solution, and ISDIN Si Nails across the region.
• Ab-BioticscoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes probiotic products from Ab-Biotics including AB-IMMUNO (immune health), AB-COLIC (infant colic), AB-LIFE (cardiovascular health), AB Mind (mental health/gut-brain axis), AB Sakei (atopic dermatitis), AB-Digest (digestive health), and PROBIO i3.1 (irritable bowel syndrome) across the region.
• ViatriscoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes hyaluronic acid viscosupplementation products from Viatris including SUPLASYN and GO-ON for the treatment of osteoarthritis across the Central American and Caribbean region. Products have been launched in Guatemala, Honduras, and El Salvador.
• AtnahscoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes bone health and oncology support products from Atnahs including Bonviva (ibandronic acid for osteoporosis), Bondronat (ibandronic acid concentrate for infusion), and Kytril (granisetron for chemotherapy-induced nausea) across the region.
• SalvatcoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes specialty pharmaceutical products from Salvat including Cetraxal Plus, Cortifil, Ebernet, Levogastrol, Vinciseptil Ótico, and Cetraxal Otico for dermatological, otological, and gastroenterological conditions across the region.
• Unión QuímicacoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes reproductive and hormonal health products from Unión Química including Microgynon, Triquilar, Climene, and Femiane (oral contraceptives and hormone replacement therapy) across the region.
• FertypharmcoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes fertility and reproductive health nutritional supplements from Fertypharm including Fertybiotic Mujer, Fertybiotic Embarazo, and Fertybiotic Hombre across the Central American and Caribbean region.
• MedinfarcoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes ALOPEXYL (minoxidil 50 mg) hair loss treatment from Medinfar across the Central American and Caribbean region.
• CarnotcoreChannel Partner/ Reseller/ DistributorMD Pharma commercializes cardiovascular products from Carnot including Ki-CAB (potassium canrenoate) and DOSTEIN (not specified) in the Central American and Caribbean region.
• GFIcoreStrategic or Co-development PartnerMD Pharma belongs to GFI (Grupo Farmacéutico Internacional), one of the most important Pharmaceutical Holdings in the region. GFI is home to multi-format companies dedicated to the development, marketing, and distribution of health products. MD Pharma operates within the GFI holding structure, benefiting from innovation and exclusivity in services for the private and institutional market.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Syneos Health: Syneos Health is a leading contract sales organization (CSO) offering outsourced medical representatives, commercialization, and medical affairs for pharma clients. Its contract commercial model mirrors what MD Pharma provides to AbbVie, AstraZeneca, and Allergan across Central America.
• Ogilvy Health: Ogilvy Health is a global pharma/health advertising and brand promotion agency serving top-20 pharma manufacturers. It overlaps with MD Pharma's promotional and HCP-marketing function but operates in paid media/communications rather than field sales and distribution.
• McCann Health: McCann Health is a leading global pharma/health creative and commercialization agency. Similar in serving pharmaceutical brand teams with promotional and HCP-engagement services, though at global scale and focused on creative communications rather than distribution and field sales.
• IQVIA: IQVIA is the largest global contract sales and commercial services provider for pharmaceutical companies, running medical-rep field forces, regulatory, and pharmacovigilance services. While much larger and globally diversified, its contract commercial services are directly analogous to MD Pharma's outsourced pharma commercialization model — just at global rather than Central American scale.
• Havas Health & You: Havas Health is a global healthcare communications network running pharma promotional campaigns, sales force support, and medical communications. Comparable in promotional services delivered to pharma clients, although built on a marketing-led model rather than MD Pharma's distribution-and-regulatory approach.
• Publicis Health: Publicis Health is a major healthcare advertising and commercialization agency that runs marketing, sales, and medical communications for pharma clients. Comparable in function (pharma promotional services delivered to HCPs) though global and marketing-led rather than MD Pharma's distribution-anchored model.
• Ashfield Health (UDG/INC Research): Ashfield Health (part of UDG/now part of Inizio) operates global contract sales, patient solutions, and medical communications for pharmaceutical manufacturers. Like MD Pharma, it serves as the outsourced commercial arm for pharma clients, though at greater scale across Europe and North America.

Regional players

• Genfar (Sanofi): Genfar is Sanofi's generics/multisource brand across Latin America with broad distribution in Central America and the Andean region. Overlap with MD Pharma in specialty pharma distribution footprint across overlapping LatAm geographies.
• Eurofarma: Eurofarma is a leading Latin American pharmaceutical company with manufacturing, distribution, and commercialization across Brazil and 20+ LatAm countries. Comparable as a LatAm pharma commercial player, though vertically integrated as a manufacturer unlike MD Pharma's intermediary model.

Emerging players

• Indegene: Indegene provides outsourced pharma commercialization, medical affairs, and digital engagement services globally, particularly to specialty pharma clients. It represents a tech-enabled, emerging CSO with overlapping service offerings to MD Pharma but oriented toward digital channels and analytics rather than field sales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/mdpharma.cam
• LinkedInlinkedin.com/showcase/somosmdpharma
• Instagraminstagram.com/mdpharma_cam

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MD Pharma